We adopted this streamlined workflow to quantitatively detect gene alterations (i.e., Ewing sarcoma protein (EWS) gene rearrangements in Ewing sarcoma[16] and KRAS mutations in pancreatic cancer[17] patients. Here, KRAS is linked to familial pancreatic carcinoma.